Condition
taVNS
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
67%
2 of 3 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Completed3
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07256080Not ApplicableNot Yet Recruiting
Effects of Transcutaneous Auricular Vagus Nerve Stimulation on Cognitive Performance and Sex Differences
NCT06763913Not ApplicableCompletedPrimary
taVNS Reduces Postoperative Pain and Complications in Patients With Gastric and Intestinal Tumors
NCT04812015Not ApplicableCompleted
Learning and Ear Stimulation
NCT05254080Not ApplicableCompletedPrimary
taVNS Cold Pressor
Showing all 4 trials